#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleomorphic leiomyosarcoma Growth hormone deficiency Henoch-Schonlein purpura Dupuytren's contracture Fungal infection Arginase deficiency Autologous haematopoietic stem cell transplant Tourette's disorder Antiphospholipid syndrome Cardiomyopathy Spinal muscular atrophy Liposarcoma Atypical haemolytic uraemic syndrome Small for dates baby Wiskott-Aldrich syndrome More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Trials in Disease Chondrosarcoma metastatic – Diagnostics Synovial sarcoma recurrent – Diagnostics Pemphigus – Treatment Pulmonary sarcoidosis – Life with Disease Sarcoma – Basic Information Hereditary hypophosphataemic rickets Inclusion body myositis – Treatment Haemophilia A with anti factor VIII – Basic Information Factor IX deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sonidegib Sumatriptan Succinate Bi 764524 Glatiramer Acetate Omp66 Chlorpromazine Taldefgrobep Alfa Fosphenytoin Sodium Rozanolixizumab Deoxyribonucleic Acid S227928 Anastrozole Opevesostat Siltuximab Regn7075 Bempikibart Rivaroxaban Bomedemstat IMB 101 TX000045 More therapies…

    Learn about Your Condition

    Alpha-1 antitrypsin deficiency Transitional cell carcinoma Hydrocephalus Essential hypertension Binge eating Lichen planopilaris Peptostreptococcus infection Major depression Corneal graft failure Indolent systemic mastocytosis Erdheim-Chester disease Hypervolaemia Chorea Lip and/or oral cavity cancer Hip fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Transient ischaemic attack

  • Study on Metabolic Impairment in ALS and TIA Patients Using Hyperpolarized Pyruvate MRI

    Recruiting

    2 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Atrial fibrillation
    • Cardiac failure
    Investigated Drugs:
    • Allopurinol
    Poland

  • Study on Stopping Atorvastatin in Frail Patients Aged 70+ with Recent Ischemic Stroke or Transient Ischemic Attack

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Ischaemic stroke
    Investigated Drugs:
    • Atorvastatin
    The Netherlands

  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Ischaemic stroke
    Investigated Drugs:
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Finland +14

  • Study on Brain Inflammation in Stroke Patients Using Ficolin-2, Gadoteric Acid, and 18F-DPA-714

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Cerebrovascular accident
    Investigated Drugs:
    • Gadoteric Acid
    • N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!